MoonLake Immunotherapeutics (MLTX) Other Non Operating Income (2021 - 2026)

MoonLake Immunotherapeutics' Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$359000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 105.06% year-over-year to -$359000.0; the TTM figure through Mar 2026 stood at $7.0 million (down 31.37% YoY), while the FY2025 annual figure was $641000.0, down 97.1% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$359000.0, down from $525000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $7.2 million in Q4 2023, with the low at -$359000.0 in Q1 2026.
• The 5-year median for Other Non Operating Income is $39157.0 (2023), against an average of $1.4 million.
• The sharpest annual moves came in 2022 and 2024: Other Non Operating Income surged 10259.7% in 2022, then sank 396.24% in 2024.
• MoonLake Immunotherapeutics' Other Non Operating Income stood at -$186990.0 in 2022, then soared by 3942.69% to $7.2 million in 2023, then sank by 55.1% to $3.2 million in 2024, then sank by 83.73% to $525000.0 in 2025, then tumbled by 168.38% to -$359000.0 in 2026.
• Business Quant data shows MLTX's Other Non Operating Income at -$359000.0 in Q1 2026, $525000.0 in Q4 2025, and $8000.0 in Q3 2025.